Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan
Mortality rates from breast cancer have steadily decreased in women since 1989 which has been attributed to progress made in early detection and improved treatment. The discovery and application of new and novel antibodies to aid pathologist’s in detection, classification, and prognosis of breast cancer continues to advance with p120 + E-cadherin, CK5/14 + p63 + CK7/18 and Folate Receptor alpha. Biocare Medical is an innovator in breast focused antibody IHC by offering a full menu of primary antibodies, antibody cocktails, and our newly released line of Supernova antibodies which allow for tailor made cocktails in your own lab.
Beta-Catenin 14/Beta-Catenin, Calponin, c-erB-2 / HER2 , Cytokeratin 7, E-Cadherin, Estrogen Receptor (ER), Folate Receptor alpha, GCDFP-15, Ki-67, Mammaglobin, p53, p63, p40, Phospho-Histone H3 , Progesterone Receptor (PR), Progesterone Receptor (PR), PTEN